查詢結果分析
來源資料
相關文獻
- Clinical Presentations of Methamidophos Poisoning
- Prognostic Factors of Organophosphate Poisoning between the Death and Survival Groups
- Comparison of the Outcome of Extremely-Low-Birth-Weight Infants between Two Periods
- 精神科專科醫院急性住院患者之死亡率
- 臺灣地區死亡率現況的實證研究
- Factors Affecting the Mortality of Sick Newborns Admitted to intensive Care Units
- 機動車事故傷害發生地、死亡地與戶籍地關係之初探:花東經驗
- 我國出生通報制度建立後對嬰兒死亡率之影響分析
- 臺灣歷史上的疾病與死亡
- 魚池中有機磷農藥殘留偵測技術探討
頁籤選單縮合
題 名 | Clinical Presentations of Methamidophos Poisoning=達馬松中毒之臨床表徵 |
---|---|
作 者 | 林增記; 陳漢文; 江大雄; 洪東榮; 李宏萍; 劉冠廷; | 書刊名 | 臺灣急診醫學會醫誌 |
卷 期 | 8:4 民95.12 |
頁 次 | 頁121-125 |
分類號 | 418.733 |
關鍵詞 | 達馬松; 有機磷; 死亡率; 巴姆; Methamidophos; Organophosphate; Mortality; Pralidoxime; |
語 文 | 英文(English) |
中文摘要 | 目的:達馬松農藥之毒性在世界衛生組織歸於第一級類之有機磷,本計劃為前瞻性連續個案收集之研究,將三級教學醫院達馬松中毒個案收錄在本研究,我們研究達馬松之臨床表現及評估他的治療方法。方法:我們紀錄人口統計學的資料、達馬松服食量、昏迷期間、住院期間、呼吸器使用期間、胸部X光發現、白血球記數、乙醯膽鹼醋海濃度、血漿膽鹼醋海濃度、阿托平使用總量、阿托平使用期間、巴姆使用總量、巴姆使用期間、尿液最高達馬松濃度、尿液達馬松出現濃度、心肺復甦術和死亡案例,並且每八小時紀錄尿液,用氣相層析法\光焰光度偵測法和氣相層析法\質譜法等檢測尿液達馬松,並紀錄尿液達馬松最高濃度。由於病人數目少及非母數,我們只用簡單的描述性統計學方法。結果:我們收集15個達馬松個案中毒,有8個男性7個女性,尿液達馬松檢測最長出現17天,有6位病人接受心肺復甦術,死亡率為33%,死亡原因為吸入性肺炎引起敗血性休克、頑固性肺水腫或心因性休克。結論:研究臨床判斷之巴姆治療時間並沒有辦法完全超過達馬松尿液存在之時間,本計劃達馬松個案中毒死亡率比其他有機磷中毒報告偏高,建議可再增加巴姆期間及巴姆每日平均用量。 |
英文摘要 | Objective: Methamidophos is a WHO class I organophosphate that is an extremely and highly hazardous pesticide. In this prospective case series study, patients in a tertiary-care medical center who were exposed to methamidophos were included in this study. The aim of this study was to determine the clinical presentations of methamiophos poisoning and evaluate the treatment method. Method: We recorded the demographic data, amount of consumption, duration of coma, duration of hospital stay, duration of ventilator use, findings of chest x ray, white blood cell count, acetylcholinesterase concentration, plasma cholinesterase concentration, total atropine amount, duration of atropine use, total pralidoxime (PAM) amount, duration of PAM therapy, peak concentration of methamidophos in the urine, duration of methamidophos in the urine, cardiopulmonary resuscitation and the cause of death. The Q8h collected urine was evaluated using GC/FPD and GC/MS for organophosphate and peak concentration was recorded. Due to the small case numbers with no parameters, we used simple descriptive analysis. Results: There were 15 cases of methamidophos poisonings including eight men and seven women in this study. The maximum duration of PAM therapy was 11 days. The maximum duration of methamidophos in the urine was 17 days. A total of six cases received cardiopulmonary resuscitation. The mortality rate was 33%. The reasons of death were septic shock with aspiration pneumonia, intractable pulmonary edema or cardiogenic shock. Conclusion: The duration of PAM therapy did not completely cover the duration of methamidophos in the urine according to clinical evaluations. The mortality rate of methamidophos poisoning in our study was higher than those of other organophosphate poisonings reported. Increases in the duration of PAM therapy and increases in the average daily dosages are recommended. |
本系統中英文摘要資訊取自各篇刊載內容。